查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1571746

乾眼症治療市場規模/佔有率/趨勢分析報告：按類型、藥物、產品、劑型、銷售管道、分銷管道、地區、細分趨勢：2024-2030

Dry Eye Syndrome Treatment Market Size, Share & Trends Analysis Report By Type (Evaporative, Aqueous Deficient), By Drug, By Product, By Dosage Form, By Sales Channel, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

乾眼症治療市場的成長與趨勢：

根據Grand View Research, Inc.最新報告，預計2030年全球乾眼症治療市場規模將達到101.3億美元，2024年至2030年複合年成長率為7.97%。

市場的成長歸因於螢幕使用量的增加、老年人口的增加以及眼科疾病患病率的上升等因素。

有螢幕設備的使用增加、電腦使用的快速成長以及眨眼次數的減少都導致了蒸發性乾眼症在全球範圍內的成長。例如，根據 2021 年《前沿雜誌》的報道，與大流行之前相比，在 COVID-19 大流行期間，成年人的螢幕使用率增加了 60-80%。接觸螢幕會使眨眼次數減少 66%，從而增加淚液蒸發並導致眼睛乾澀。

由於處方藥的接受率極低，非處方藥 (OTC) 在市場上佔據主導地位。例如，只有 10% 被診斷為乾眼症的患者接受處方箋治療，75% 的患者從未嘗試過處方箋治療。然而，診斷為乾眼症的患者人數佔所有眼科醫師諮詢的5%至35%。

此外，Zydra 和 Restasis 等現有產品需要數月或數週才能生效。此外，眼科醫師表示這些產品有耐受性問題，失敗率高達 50%。這造成了市場上未滿足的需求，預計將為未來幾年推出的研發線產品創造利潤豐厚的機會。此外，與藥品相關的法規正在阻礙整體市場的成長。例如，2020年，在監管機構對Xydra的使用提出強烈反對後，諾華被迫自願撤回在歐洲使用Xydra。

主要企業的創新和策略舉措正在推動市場發展。推出新產品是企業採取的常見策略。例如，2021年10月，Oyster Point Pharma的Tyrvaya（Varenicline溶液）鼻噴霧被FDA核准作為替代治療方法。

乾眼症治療市場報告亮點

  • 按類型分類，2023年蒸發乾眼症候群所佔比例最大。
  • 按劑型分類，由於易於取得和人們對眼科用藥的偏好增加，眼藥水在 2023 年佔據了最大的銷售佔有率。
  • 從藥物來看，Restasis作為乾眼治療處方藥的採用率很高，在2023年佔據了最大的市場佔有率。
  • 按銷售管道分類，由於消費者對網路藥局的便利性越來越偏好，預計線上藥局在預測期內將以最快的速度成長。
  • 由於乾眼症盛行率高、意識不斷提高以及治療率提高，北美在 2023 年佔據市場主導地位。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章 市場變數、趨勢與範圍

  • 市場譜系
    • 母市場分析
    • 輔助市場分析
  • 乾眼症治療市場 – 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 商業環境工具分析：乾眼症治療市場
    • 波特五力分析
    • PESTLE分析
  • 管道分析
  • 價格分析

第4章 乾眼症治療市場：類型估計與趨勢分析

  • 乾眼症治療市場：型式儀表板
  • 乾眼症治療市場：類型變異分析
  • 2018-2030 年按類型分類的市場估計與預測
  • 蒸發性乾眼症
  • 淚腺分泌過少的乾眼症

第5章 乾眼症治療市場：藥物評估及趨勢分析

  • 乾眼症治療市場：藥物儀表板
  • 乾眼症治療市場：藥物波動分析
  • 2018-2030 年按藥物分類的市場估計與預測
  • 恢復
  • 西德拉
  • 塞誇
  • 艾斯維斯
  • 蒂亞
  • 其他

第6章 乾眼症治療市場：產品估算與趨勢分析

  • 乾眼症治療市場：產品儀表板
  • 乾眼症治療市場：產品波動分析
  • 2018-2030 年按產品分類的市場估計與預測
  • Cyclosporine
  • 局部皮質類固醇
  • 人工淚液
  • 淚點塞
  • 口服歐米茄補充品
  • 其他

第7章 乾眼症治療市場：劑型估算及趨勢分析

  • 乾眼症治療市場：劑型儀表板
  • 乾眼症治療市場：劑型變化分析
  • 2018-2030 年按劑型分類的市場估計與預測
  • 凝膠
  • 眼液
  • 膠囊和片劑
  • 眼藥水
  • 軟膏

第8章乾眼症治療市場：銷售管道估算及趨勢分析

  • 乾眼症治療市場：銷售管道儀表板
  • 乾眼症治療市場：銷售管道波動分析
  • 2018-2030 年按銷售管道分類的市場估計與預測
  • 處方箋
  • 在商店

第9章乾眼症治療市場：通路估算及趨勢分析

  • 乾眼症治療市場：分銷通路儀表板
  • 乾眼症治療市場：通路波動分析
  • 2018-2030 年按分銷管道分類的市場估計和預測
  • 醫院藥房
  • 網路藥房
  • 零售藥房

第10章乾眼症治療市場：區域估計與趨勢分析

  • 乾眼症治療市場：2022 年和 2030 年區域變化分析
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第11章競爭格局

  • 公司分類
  • 2022 年企業市場佔有率分析
  • 策略規劃
  • 公司簡介/上市公司
    • NOVARTIS AG.
    • ABBVIE, INC.
    • SUN PHARMACEUTICAL INDUSTRIES LTD.
    • SANTEN PHARMACEUTICAL CO., LTD.
    • AFT PHARMACEUTICALS
    • JOHNSON &JOHNSON SERVICES, INC.
    • OTSUKA PHARMACEUTICAL CO., LTD.
    • OASIS MEDICAL.
    • OYSTER POINT PHARMA, INC.
    • BAUSCH &LOMB
Product Code: GVR-4-68039-974-4

Dry Eye Syndrome Treatment Market Growth & Trends:

The global dry eye syndrome treatment market size is expected to reach USD 10.13 billion by 2030, registering a CAGR of 7.97% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growth of the market is attributed to factors such as the increasing use of screens, the rising geriatric population, and a heightened prevalence of eye diseases.

The heightened use of devices with a screen, surging use of computers, and a decreased number of blinks are subsequently leading to the growth of evaporative dry eye syndrome globally. For instance, as per Frontiers Journal in 2021, when compared to pre-pandemic years, the use of screens has increased by 60-80% in adults during the COVID-19 pandemic. The exposure to the screen leads to a 66% decreased blinking rate, thus escalating the evaporation of tears and leading to dry eye disease.

Over-the-counter (OTC) products predominate the marketplace due to the extremely low acceptance of prescription products. For instance, only 10% of the diagnosed population is on prescription therapies, while 75% of the population has never tried prescription therapy. However, the number of patients diagnosed with dry eye syndrome accounts for 5-35% of overall ophthalmologist visits.

Moreover, existing products such as Xiidra and Restasis take months or weeks to demonstrate effects. In addition, as per eye consultants, these products have tolerability issues and a failure rate of as high as 50%. This depicts an unmet need in the market and is anticipated to create a lucrative opportunity for pipeline products expected to launch in the upcoming years. Moreover, regulations associated with the drugs further hamper the growth of the overall market. For instance, in 2020, Novartis had to voluntarily withdraw the use of Xiidra in Europe after regulators raised major objections to its use of xiidra.

Innovations and strategic initiatives by key players are driving the market. New product launch is a common strategy being used by the players. For instance, in October 2021, Tyrvaya (varenicline solution) nasal spray by Oyster Point Pharma was approved by the FDA as an alternative treatment approach.

Dry Eye Syndrome Treatment Market Report Highlights:

  • By type, evaporative dry eye syndrome held the largest share in 2023 owing to the increasing prevalence of the condition and heightened screen time
  • Based on dosage form, eye drops held the largest revenue share in 2023 owing to easy availability as well as increased preference for eye drop administration of the product
  • By drug, Restasis held the largest market share in 2023 owing to its high adoption as a prescription drug for dry eye treatment
  • Based on distribution channel, online pharmacies are expected to grow at the fastest rate over the forecast period due to the increased consumer preference for online pharmacies owing to the convenience
  • North America dominated the market in 2023 due to the high prevalence of the disease, surging awareness, and enhanced treatment rate

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Disease
    • 1.2.2. Treatment
    • 1.2.3. Regional Scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Disease outlook
    • 2.2.2. Treatment outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Market Variables, Trends, and Scope

  • 3.1. Market Lineage
    • 3.1.1. Parent Market Analysis
    • 3.1.2. Ancillary Market Analysis
  • 3.2. Dry Eye Syndrome Treatment Market - Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing geriatric population
      • 3.2.1.2. Increasing Prevalence of Dry Eye Syndrome
      • 3.2.1.3. Robust product pipeline
      • 3.2.1.4. Growing disease awareness and increasing use of contact lenses
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Competition from generic products
      • 3.2.2.2. High cost of treatments and lack of awareness among the general population in low- and middle-income countries
  • 3.3. Business Environmental Tools Analysis: Dry Eye Syndrome Treatment Market
    • 3.3.1. Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
  • 3.4. Pipeline Analysis
  • 3.5. Pricing Analysis

Chapter 4. Dry Eye Syndrome Treatment Market: Type Estimates & Trend Analysis

  • 4.1. Dry Eye Syndrome Treatment Market: Type Dashboard
  • 4.2. Dry Eye Syndrome Treatment Market: Type Movement Analysis
  • 4.3. Dry Eye Syndrome Treatment Market Estimates and Forecasts, By Type, 2018 - 2030 (USD Million)
  • 4.4. Evaporative Dry Eye Syndrome
    • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Aqueous Deficient Dry Eye Syndrome
    • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Dry Eye Syndrome Treatment Market: Drug Estimates & Trend Analysis

  • 5.1. Dry Eye Syndrome Treatment Market: Drug Dashboard
  • 5.2. Dry Eye Syndrome Treatment Market: Drug Movement Analysis
  • 5.3. Dry Eye Syndrome Treatment Market Estimates and Forecasts, By Drug, 2018 - 2030 (USD Million)
  • 5.4. Restasis
    • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Xiidra
    • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Cequa
    • 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Eysuvis
    • 5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.8. Tyrvaya
    • 5.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.9. Others
    • 5.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Dry Eye Syndrome Treatment Market: Product Estimates & Trend Analysis

  • 6.1. Dry Eye Syndrome Treatment Market: Product Dashboard
  • 6.2. Dry Eye Syndrome Treatment Market: Product Movement Analysis
  • 6.3. Dry Eye Syndrome Treatment Market Estimates and Forecasts, By Product, 2018 - 2030 (USD Million)
  • 6.4. Cyclosporine
    • 6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Topical Corticosteroids
    • 6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Artificial Tears
    • 6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Punctal Plugs
    • 6.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.2. Removable Punctal Plugs
      • 6.7.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.3. Dissolvable Punctal Plugs
      • 6.7.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8. Oral Omega Supplements
    • 6.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9. Others
    • 6.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Dry Eye Syndrome Treatment Market: Dosage Form Estimates & Trend Analysis

  • 7.1. Dry Eye Syndrome Treatment Market: Dosage Form Dashboard
  • 7.2. Dry Eye Syndrome Treatment Market: Dosage Form Movement Analysis
  • 7.3. Dry Eye Syndrome Treatment Market Estimates and Forecasts, By Dosage Form, 2018 - 2030 (USD Million)
  • 7.4. Gels
    • 7.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Eye Solutions
    • 7.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Capsules & Tablets
    • 7.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Eye Drops
    • 7.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. Ointments
    • 7.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Dry Eye Syndrome Treatment Market: Sales Channel Estimates & Trend Analysis

  • 8.1. Dry Eye Syndrome Treatment Market: Sales Channel Dashboard
  • 8.2. Dry Eye Syndrome Treatment Market: Sales Channel Movement Analysis
  • 8.3. Dry Eye Syndrome Treatment Market Estimates and Forecasts, By Sales Channel, 2018 - 2030 (USD Million)
  • 8.4. Prescription
    • 8.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5. OTC
    • 8.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Dry Eye Syndrome Treatment Market: Distribution Channel Estimates & Trend Analysis

  • 9.1. Dry Eye Syndrome Treatment Market: Distribution Channel Dashboard
  • 9.2. Dry Eye Syndrome Treatment Market: Distribution Channel Movement Analysis
  • 9.3. Dry Eye Syndrome Treatment Market Estimates and Forecasts, By Distribution Channel, 2018 - 2030 (USD Million)
  • 9.4. Hospital Pharmacies
    • 9.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5. Online Pharmacies
    • 9.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6. Retail Pharmacies
    • 9.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 10. Dry Eye Syndrome Treatment Market: Regional Estimates & Trend Analysis

  • 10.1. Dry Eye Syndrome Treatment Market: Regional Movement Analysis, 2022 & 2030
  • 10.2. North America
    • 10.2.1. North America Dry Eye Syndrome Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
    • 10.2.2. U.S.
      • 10.2.2.1. Key Country Dynamics
      • 10.2.2.2. Competitive Scenario
      • 10.2.2.3. Prevalence Insights
      • 10.2.2.4. Regulatory Framework
      • 10.2.2.5. Reimbursement Structure
      • 10.2.2.6. U.S. Dry Eye Syndrome Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
    • 10.2.3. Canada
      • 10.2.3.1. Key Country Dynamics
      • 10.2.3.2. Competitive Scenario
      • 10.2.3.3. Prevalence Insights
      • 10.2.3.4. Regulatory Framework
      • 10.2.3.5. Reimbursement Structure
      • 10.2.3.6. Canada Dry Eye Syndrome Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
  • 10.3. Europe
    • 10.3.1. Europe Dry Eye Syndrome Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
    • 10.3.2. UK
      • 10.3.2.1. Key Country Dynamics
      • 10.3.2.2. Competitive Scenario
      • 10.3.2.3. Prevalence Insights
      • 10.3.2.4. Regulatory Framework
      • 10.3.2.5. Reimbursement Structure
      • 10.3.2.6. UK Dry Eye Syndrome Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
    • 10.3.3. Germany
      • 10.3.3.1. Key Country Dynamics
      • 10.3.3.2. Competitive Scenario
      • 10.3.3.3. Prevalence Insights
      • 10.3.3.4. Regulatory Framework
      • 10.3.3.5. Reimbursement Structure
      • 10.3.3.6. Germany Dry Eye Syndrome Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
    • 10.3.4. France
      • 10.3.4.1. Key Country Dynamics
      • 10.3.4.2. Competitive Scenario
      • 10.3.4.3. Prevalence Insights
      • 10.3.4.4. Regulatory Framework
      • 10.3.4.5. Reimbursement Structure
      • 10.3.4.6. France Dry Eye Syndrome Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
    • 10.3.5. Italy
      • 10.3.5.1. Key Country Dynamics
      • 10.3.5.2. Competitive Scenario
      • 10.3.5.3. Prevalence Insights
      • 10.3.5.4. Regulatory Framework
      • 10.3.5.5. Reimbursement Structure
      • 10.3.5.6. Italy Dry Eye Syndrome Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
    • 10.3.6. Spain
      • 10.3.6.1. Key Country Dynamics
      • 10.3.6.2. Competitive Scenario
      • 10.3.6.3. Prevalence Insights
      • 10.3.6.4. Regulatory Framework
      • 10.3.6.5. Reimbursement Structure
      • 10.3.6.6. Spain Dry Eye Syndrome Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
    • 10.3.7. Denmark
      • 10.3.7.1. Key Country Dynamics
      • 10.3.7.2. Competitive Scenario
      • 10.3.7.3. Prevalence Insights
      • 10.3.7.4. Regulatory Framework
      • 10.3.7.5. Reimbursement Structure
      • 10.3.7.6. Denmark Dry Eye Syndrome Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
    • 10.3.8. Sweden
      • 10.3.8.1. Key Country Dynamics
      • 10.3.8.2. Competitive Scenario
      • 10.3.8.3. Prevalence Insights
      • 10.3.8.4. Regulatory Framework
      • 10.3.8.5. Reimbursement Structure
      • 10.3.8.6. Sweden Dry Eye Syndrome Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
    • 10.3.9. Norway
      • 10.3.9.1. Key Country Dynamics
      • 10.3.9.2. Competitive Scenario
      • 10.3.9.3. Prevalence Insights
      • 10.3.9.4. Regulatory Framework
      • 10.3.9.5. Reimbursement Structure
      • 10.3.9.6. Norway Dry Eye Syndrome Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
  • 10.4. Asia Pacific
    • 10.4.1. Asia Pacific Dry Eye Syndrome Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
    • 10.4.2. Japan
      • 10.4.2.1. Key Country Dynamics
      • 10.4.2.2. Competitive Scenario
      • 10.4.2.3. Prevalence Insights
      • 10.4.2.4. Regulatory Framework
      • 10.4.2.5. Reimbursement Structure
      • 10.4.2.6. Japan Dry Eye Syndrome Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
    • 10.4.3. China
      • 10.4.3.1. Key Country Dynamics
      • 10.4.3.2. Competitive Scenario
      • 10.4.3.3. Prevalence Insights
      • 10.4.3.4. Regulatory Framework
      • 10.4.3.5. Reimbursement Structure
      • 10.4.3.6. China Dry Eye Syndrome Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
    • 10.4.4. India
      • 10.4.4.1. Key Country Dynamics
      • 10.4.4.2. Competitive Scenario
      • 10.4.4.3. Prevalence Insights
      • 10.4.4.4. Regulatory Framework
      • 10.4.4.5. Reimbursement Structure
      • 10.4.4.6. India Dry Eye Syndrome Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
    • 10.4.5. Australia
      • 10.4.5.1. Key Country Dynamics
      • 10.4.5.2. Competitive Scenario
      • 10.4.5.3. Prevalence Insights
      • 10.4.5.4. Regulatory Framework
      • 10.4.5.5. Reimbursement Structure
      • 10.4.5.6. Australia Dry Eye Syndrome Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
    • 10.4.6. Thailand
      • 10.4.6.1. Key Country Dynamics
      • 10.4.6.2. Competitive Scenario
      • 10.4.6.3. Prevalence Insights
      • 10.4.6.4. Regulatory Framework
      • 10.4.6.5. Reimbursement Structure
      • 10.4.6.6. Thailand Dry Eye Syndrome Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
    • 10.4.7. South Korea
      • 10.4.7.1. Key Country Dynamics
      • 10.4.7.2. Competitive Scenario
      • 10.4.7.3. Prevalence Insights
      • 10.4.7.4. Regulatory Framework
      • 10.4.7.5. Reimbursement Structure
      • 10.4.7.6. South Korea Dry Eye Syndrome Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
  • 10.5. Latin America
    • 10.5.1. Latin America Dry Eye Syndrome Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
    • 10.5.2. Brazil
      • 10.5.2.1. Key Country Dynamics
      • 10.5.2.2. Competitive Scenario
      • 10.5.2.3. Prevalence Insights
      • 10.5.2.4. Regulatory Framework
      • 10.5.2.5. Reimbursement Structure
      • 10.5.2.6. Brazil Dry Eye Syndrome Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
    • 10.5.3. Mexico
      • 10.5.3.1. Key Country Dynamics
      • 10.5.3.2. Competitive Scenario
      • 10.5.3.3. Prevalence Insights
      • 10.5.3.4. Regulatory Framework
      • 10.5.3.5. Reimbursement Structure
      • 10.5.3.6. Mexico Dry Eye Syndrome Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
    • 10.5.4. Argentina
      • 10.5.4.1. Key Country Dynamics
      • 10.5.4.2. Competitive Scenario
      • 10.5.4.3. Prevalence Insights
      • 10.5.4.4. Regulatory Framework
      • 10.5.4.5. Reimbursement Structure
      • 10.5.4.6. Argentina Dry Eye Syndrome Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
  • 10.6. Middle East & Africa
    • 10.6.1. Middle East & Africa Dry Eye Syndrome Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
    • 10.6.2. South Africa
      • 10.6.2.1. Key Country Dynamics
      • 10.6.2.2. Competitive Scenario
      • 10.6.2.3. Prevalence Insights
      • 10.6.2.4. Regulatory Framework
      • 10.6.2.5. Reimbursement Structure
      • 10.6.2.6. South Africa Dry Eye Syndrome Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
    • 10.6.3. Saudi Arabia
      • 10.6.3.1. Key Country Dynamics
      • 10.6.3.2. Competitive Scenario
      • 10.6.3.3. Prevalence Insights
      • 10.6.3.4. Regulatory Framework
      • 10.6.3.5. Reimbursement Structure
      • 10.6.3.6. Saudi Arabia Dry Eye Syndrome Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
    • 10.6.4. UAE
      • 10.6.4.1. Key Country Dynamics
      • 10.6.4.2. Competitive Scenario
      • 10.6.4.3. Prevalence Insights
      • 10.6.4.4. Regulatory Framework
      • 10.6.4.5. Reimbursement Structure
      • 10.6.4.6. UAE Dry Eye Syndrome Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
    • 10.6.5. Kuwait
      • 10.6.5.1. Key Country Dynamics
      • 10.6.5.2. Competitive Scenario
      • 10.6.5.3. Prevalence Insights
      • 10.6.5.4. Regulatory Framework
      • 10.6.5.5. Reimbursement Structure
      • 10.6.5.6. Kuwait Dry Eye Syndrome Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)

Chapter 11. Competitive Landscape

  • 11.1. Company Categorization
  • 11.2. Company Market Share Analysis, 2022
  • 11.3. Strategy Mapping
  • 11.4. Company Profiles/Listing
    • 11.4.1. NOVARTIS AG.
      • 11.4.1.1. Overview
      • 11.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 11.4.1.3. Product Benchmarking
      • 11.4.1.4. Strategic Initiatives
    • 11.4.2. ABBVIE, INC.
      • 11.4.2.1. Overview
      • 11.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 11.4.2.3. Product Benchmarking
      • 11.4.2.4. Strategic Initiatives
    • 11.4.3. SUN PHARMACEUTICAL INDUSTRIES LTD.
      • 11.4.3.1. Overview
      • 11.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 11.4.3.3. Product Benchmarking
      • 11.4.3.4. Strategic Initiatives
    • 11.4.4. SANTEN PHARMACEUTICAL CO., LTD.
      • 11.4.4.1. Overview
      • 11.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 11.4.4.3. Product Benchmarking
      • 11.4.4.4. Strategic Initiatives
    • 11.4.5. AFT PHARMACEUTICALS
      • 11.4.5.1. Overview
      • 11.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 11.4.5.3. Product Benchmarking
      • 11.4.5.4. Strategic Initiatives
    • 11.4.6. JOHNSON & JOHNSON SERVICES, INC.
      • 11.4.6.1. Overview
      • 11.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 11.4.6.3. Product Benchmarking
      • 11.4.6.4. Strategic Initiatives
    • 11.4.7. OTSUKA PHARMACEUTICAL CO., LTD.
      • 11.4.7.1. Overview
      • 11.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 11.4.7.3. Product Benchmarking
      • 11.4.7.4. Strategic Initiatives
    • 11.4.8. OASIS MEDICAL.
      • 11.4.8.1. Overview
      • 11.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 11.4.8.3. Product Benchmarking
      • 11.4.8.4. Strategic Initiatives
    • 11.4.9. OYSTER POINT PHARMA, INC.
      • 11.4.9.1. Overview
      • 11.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 11.4.9.3. Product Benchmarking
      • 11.4.9.4. Strategic Initiatives
    • 11.4.10. BAUSCH & LOMB
      • 11.4.10.1. Overview
      • 11.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 11.4.10.3. Product Benchmarking
      • 11.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 Incidence of Diseases
  • Table 4 Global Dry Eye Syndrome Treatment Market, By Region, 2018 - 2030 (USD Million)
  • Table 5 Global Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 6 Global Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 7 Global Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 8 Global Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 9 Global Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • Table 10 Global Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • Table 11 North America Dry Eye Syndrome Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 12 North America Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 13 North America Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 14 North America Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 15 North America Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 16 North America Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • Table 17 North America Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • Table 18 U.S. Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 19 U.S. Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 20 U.S. Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 21 U.S. Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 22 U.S. Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • Table 23 U.S. Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • Table 24 Canada Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 25 Canada Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 26 Canada Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 27 Canada Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 28 Canada Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • Table 29 Canada Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • Table 30 Europe Dry Eye Syndrome Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 31 Europe Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 32 Europe Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 33 Europe Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 34 Europe Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 35 Europe Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • Table 36 Europe Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • Table 37 Germany Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 38 Germany Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 39 Germany Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 40 Germany Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 41 Germany Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • Table 42 Germany Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • Table 43 UK Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 44 UK Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 45 UK Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 46 UK Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 47 UK Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • Table 48 UK Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • Table 49 France Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 50 France Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 51 France Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 52 France Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 53 France Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • Table 54 France Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • Table 55 Italy Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 56 Italy Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 57 Italy Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 58 Italy Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 59 Italy Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • Table 60 Italy Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • Table 61 Spain Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 62 Spain Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 63 Spain Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 64 Spain Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 65 Spain Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • Table 66 Spain Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • Table 67 Asia Pacific Dry Eye Syndrome Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 68 Asia Pacific Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 69 Asia Pacific Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 70 Asia pacific Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 71 Asia Pacific Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 72 Asia Pacific Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • Table 73 Asia Pacific Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • Table 74 Japan Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 75 Japan Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 76 Japan Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 77 Japan Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 78 Japan Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • Table 79 Japan Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • Table 80 China Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 81 China Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 82 China Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 83 China Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 84 China Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • Table 85 China Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • Table 86 India Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 87 India Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 88 India Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 89 India Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 90 India Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • Table 91 India Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • Table 92 South Korea Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 93 South Korea Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 94 South Korea Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 95 South Korea Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 96 South Korea Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • Table 97 South Korea Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • Table 98 Australia Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 99 Australia Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 100 Australia Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 101 Australia Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 102 Australia Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • Table 103 Australia Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • Table 104 Latin America Dry Eye Syndrome Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 105 Latin America Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 106 Latin America Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 107 Latin America Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 108 Latin America Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 109 Latin America Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • Table 110 Latin America Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • Table 111 Brazil Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 112 Brazil Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 113 Brazil Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 114 Brazil Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 115 Brazil Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • Table 116 Brazil Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • Table 117 Mexico Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 118 Mexico Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 119 Mexico Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 120 Mexico Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 121 Mexico Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • Table 122 Mexico Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • Table 123 Argentina Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 124 Argentina Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 125 Argentina Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 126 Argentina Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 127 Argentina Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • Table 128 Argentina Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • Table 129 Middle East & Africa Dry Eye Syndrome Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 130 Middle East & Africa Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 131 Middle East & Africa Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 132 Middle East & Africa Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 133 Middle East & Africa Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 134 Middle East & Africa Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • Table 135 Middle East & Africa Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • Table 136 Saudi Arabia Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 137 Saudi Arabia Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 138 Saudi Arabia Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 139 Saudi Arabia Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 140 Saudi Arabia Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • Table 141 Saudi Arabia Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • Table 142 South Africa Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 143 South Africa Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 144 South Africa Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 145 South Africa Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 146 South Africa Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • Table 147 South Africa Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • Table 148 UAE Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 149 UAE Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 150 UAE Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 151 UAE Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 152 UAE Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • Table 153 UAE Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Dry eye syndrome treatment market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Dry eye syndrome treatment market snapshot
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook, revenue, 2023, (USD Million)
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Dry eye syndrome treatment market driver impact
  • Fig. 14 Dry eye syndrome treatment market restraint impact
  • Fig. 15 SWOT analysis, by factor (political & legal, economic, and technological)
  • Fig. 16 Industry Analysis - Porter's
  • Fig. 17 Strategy mapping
  • Fig. 18 Dry eye syndrome treatment market: type outlook and key takeaways
  • Fig. 19 Dry eye syndrome treatment market: type movement analysis & market share 2023 & 2030
  • Fig. 20 Evaporative dry eye syndrome treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Aqueous dry eye syndrome treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Dry eye syndrome treatment market: product outlook and key takeaways
  • Fig. 23 Dry eye syndrome treatment market: product movement analysis & market share 2023 & 2030
  • Fig. 24 Gels market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Eye solutions market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Capsules and tablets market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Eye solutions market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Ointments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Dry eye syndrome treatment market: distribution channel outlook and key takeaways
  • Fig. 30 Dry eye syndrome treatment market: distribution channel movement analysis & market share 2022 & 2030
  • Fig. 31 Hospital pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Retail pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Online pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Dry eye syndrome treatment market: Prescription outlook and key takeaways
  • Fig. 35 Dry eye syndrome treatment market: Prescription channel movement analysis & market share 2022 & 2030
  • Fig. 36 Prescription market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 OTC market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Dry eye syndrome treatment market: Product outlook and key takeaways
  • Fig. 39 Dry eye syndrome treatment market: Product channel movement analysis & market share 2022 & 2030
  • Fig. 40 Cyclosporine market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Topical Corticosteroids market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Artificial Tears market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Punctal Plugs market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Removable market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Dissolvable market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Oral Omega Supplements market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Dry eye syndrome treatment market: Drug outlook and key takeaways
  • Fig. 49 Dry eye syndrome treatment market: Drug channel movement analysis & market share 2022 & 2030
  • Fig. 50 Restasis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Xiidra market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Cequa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Eysuvis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Tyrvaya market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Dry Eye Syndrome Treatment: Regional outlook and key takeaways
  • Fig. 57 Regional outlook, 2023 & 2030
  • Fig. 58 North America
  • Fig. 59 North America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 U.S.
  • Fig. 61 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Canada
  • Fig. 63 Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 Mexico
  • Fig. 65 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 Europe
  • Fig. 67 Europe market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 UK
  • Fig. 69 UK market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 Germany
  • Fig. 71 Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 72 France
  • Fig. 73 France market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 74 Italy
  • Fig. 75 Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 76 Spain
  • Fig. 77 Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 78 Asia-Pacific
  • Fig. 79 Asia-Pacific market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 80 Japan
  • Fig. 81 Japan market estimates and forecast, 2018 - 2030(USD Million)
  • Fig. 82 China
  • Fig. 83 China market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 84 India
  • Fig. 85 India market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 86 South Korea
  • Fig. 87 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 88 Australia
  • Fig. 89 Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 90 Latin America
  • Fig. 91 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 92 Brazil
  • Fig. 93 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 94 Argentina
  • Fig. 95 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 96 Middle East & Africa
  • Fig. 97 MEA market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 98 South Africa
  • Fig. 99 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 100 Saudi Arabia
  • Fig. 101 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 102 UAE
  • Fig. 103 UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 104 Ansoff Matrix
  • Fig. 105 Market differentiators
  • Fig. 106 Key company market share analysis, 2023
  • Fig. 107 Company market position analysis
  • Fig. 108 Competitive dashboard analysis
  • Fig. 109 Regional network map